NO20002148L - CD8 som inhibitor for det cellulære immunsystem - Google Patents

CD8 som inhibitor for det cellulære immunsystem

Info

Publication number
NO20002148L
NO20002148L NO20002148A NO20002148A NO20002148L NO 20002148 L NO20002148 L NO 20002148L NO 20002148 A NO20002148 A NO 20002148A NO 20002148 A NO20002148 A NO 20002148A NO 20002148 L NO20002148 L NO 20002148L
Authority
NO
Norway
Prior art keywords
inhibitor
immune system
cellular immune
ctl
activity
Prior art date
Application number
NO20002148A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002148D0 (no
Inventor
Bent Karsten Jakobsen
George Fu Gao
Ulrich Conrad Gerth
Andrew Kelvin Sewell
Original Assignee
Avidex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avidex Ltd filed Critical Avidex Ltd
Publication of NO20002148D0 publication Critical patent/NO20002148D0/no
Publication of NO20002148L publication Critical patent/NO20002148L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70517—CD8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20002148A 1997-10-28 2000-04-27 CD8 som inhibitor for det cellulære immunsystem NO20002148L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722779.7A GB9722779D0 (en) 1997-10-28 1997-10-28 Human CD8 as an inhibitor of the cellular immune system
PCT/GB1998/003235 WO1999021576A1 (en) 1997-10-28 1998-10-28 Cd8 as an inhibitor of the cellular immune system

Publications (2)

Publication Number Publication Date
NO20002148D0 NO20002148D0 (no) 2000-04-27
NO20002148L true NO20002148L (no) 2000-06-27

Family

ID=10821228

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002148A NO20002148L (no) 1997-10-28 2000-04-27 CD8 som inhibitor for det cellulære immunsystem

Country Status (17)

Country Link
US (1) US20070191278A1 (da)
EP (1) EP1024822B1 (da)
JP (1) JP2001521005A (da)
KR (1) KR100585246B1 (da)
CN (1) CN1256147C (da)
AT (1) ATE215833T1 (da)
AU (1) AU752910B2 (da)
CA (1) CA2308463A1 (da)
DE (1) DE69804839T2 (da)
DK (1) DK1024822T3 (da)
ES (1) ES2175798T3 (da)
GB (1) GB9722779D0 (da)
HK (1) HK1031099A1 (da)
NO (1) NO20002148L (da)
NZ (1) NZ504240A (da)
PT (1) PT1024822E (da)
WO (1) WO1999021576A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929993D0 (en) * 1999-12-17 2000-02-09 Avidex Ltd Substances
GB0107628D0 (en) * 2001-03-27 2001-05-16 Avidex Ltd Substances
GB0114533D0 (en) * 2001-06-14 2001-08-08 Avidex Ltd Substances
GB0115071D0 (en) * 2001-06-20 2001-08-15 Avidex Ltd Substances
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
GB2398300A (en) * 2003-02-17 2004-08-18 Isis Innovation Method and compositions for boosting immune response
CA2574802A1 (en) * 2004-07-20 2006-02-02 Isogenis, Inc. Specific inhibition of autoimmunity and diseases associated with autoantigens
GB0510627D0 (en) 2005-05-25 2005-06-29 Avidex Ltd Polypeptides
EP2342321B1 (en) 2008-09-17 2018-04-11 Isogenis, Inc. Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
MX347078B (es) * 2010-12-09 2017-04-10 Univ Pennsylvania Uso de celulas t modificadas por receptor de antigeno quimerico para tratar cancer.
WO2016149404A1 (en) 2015-03-16 2016-09-22 California Institute Of Technology Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
CN115109120A (zh) * 2016-04-04 2022-09-27 英蒂分子公司 Cd8-特异性捕获剂、组合物及使用和制备方法
EP3519425B1 (en) 2016-09-29 2024-02-28 Indi Molecular, Inc. Compositions for detection, inhibition and imaging of indoleamine 2,3-dioxygenase 1 (ido1) and methods of making and using same
WO2018232345A1 (en) 2017-06-15 2018-12-20 Indi Molecular, Inc. Il-17f and il-17a-specific capture agents, compositions, and methods of using and making
WO2022098743A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2050346A1 (en) * 1989-03-15 1990-09-16 Mark L. Tykocinski Cd8-based pharmaceuticals
US5242687A (en) * 1989-03-15 1993-09-07 Tkb Associates Limited Partnership Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells
US5601828A (en) * 1989-03-15 1997-02-11 Tkb Associates Limited Partnership CD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftment
US5645837A (en) * 1995-01-17 1997-07-08 Thomas Jefferson University Peptides that inhibit T cell activation and methods of using the same

Also Published As

Publication number Publication date
HK1031099A1 (en) 2001-06-01
AU752910B2 (en) 2002-10-03
EP1024822B1 (en) 2002-04-10
PT1024822E (pt) 2002-09-30
ATE215833T1 (de) 2002-04-15
CA2308463A1 (en) 1999-05-06
KR20010024570A (ko) 2001-03-26
AU9637498A (en) 1999-05-17
DE69804839T2 (de) 2002-10-10
NZ504240A (en) 2002-11-26
US20070191278A1 (en) 2007-08-16
CN1256147C (zh) 2006-05-17
ES2175798T3 (es) 2002-11-16
CN1283120A (zh) 2001-02-07
WO1999021576A1 (en) 1999-05-06
GB9722779D0 (en) 1997-12-24
KR100585246B1 (ko) 2006-06-01
JP2001521005A (ja) 2001-11-06
EP1024822A1 (en) 2000-08-09
DK1024822T3 (da) 2002-08-05
NO20002148D0 (no) 2000-04-27
DE69804839D1 (de) 2002-05-16

Similar Documents

Publication Publication Date Title
DK1024822T3 (da) CD8 som inhibitor for det cellulære immunsystem
MX9707431A (es) Inhibidores de la proteina cinasa c.
EA200200990A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы дельта человека
ES2060031T3 (es) Formulacion que contiene un derivado de imidazo(4,5-c)quinoleina.
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
DK0677039T3 (da) Cyclobutanderivater som squalen-syntetase- og protein-farnesyltransferaseinhibitorer
ATE192153T1 (de) Amino-imidazo (4,5-c) chinoline
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
GR3036188T3 (en) Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
WO2003000343A3 (en) Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
IS2216B (is) Meðferðaráform við inngjöf á H+,K+ -ATPasa-hemla
FR2697252B1 (fr) Dérivés de 1,2,3,5,6,7,8,8a-octahydro-5,5,8a-triméthyl-(8abeta)-6-isoquinolineamine, leur procédé de préparation et leur utilisation en thérapeutique.
AR024138A1 (es) Inhibidores de la proliferacion celular
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
HUP0004780A2 (hu) Prosztaglandin agonisták felhasználása merevedési rendellenességek vagy impotencia kezelésében
AU7270798A (en) Antithrombotic agents
DK0825865T3 (da) Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
PT880520E (pt) Derivados da benzo¬c|quinolizina sua preparacao e uso como inibidores da 5-alfa-reductase
AU2576901A (en) Agents and methods for the treatment of proliferative diseases
BG104452A (en) New derivatives of the methylenebisphosphonic acid
HUP0002727A2 (hu) Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával
DE69812945D1 (de) Tricyclische aminooxyamide derivate als farnesyl protein transferase inhibitoren
NZ503559A (en) Compositions and methods for the control of smoking containing a xanthine oxidase inhibitor
GEP20033130B (en) Inhibitors of IMPDH Enzyme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application